The treatment outcomes of foam sclerotherapy of chronic venous incompetence at National Geriatric Hospital

  • Nguyễn Trung Anh Bệnh viện Lão khoa Trung ương
  • Bùi Thúc Quang Bệnh viện Lão khoa Trung ương
  • Nguyễn Quý Phong Bệnh viện Lão khoa Trung ương
  • Phạm Thắng Bệnh viện Lão khoa Trung ương
  • Phạm Nguyên Sơn Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

Chronic venous incompetence, foam sclerotherapy

Abstract

Objective: To evaluate the treatment results of foam sclerotherapy of 110 patients with chronic venous incompetence (CVI) at National Geriatric Hospital. Subject and method: 110 patients CVI (mean age 53.6 ± 11.9) were treated by under ultrasound guided foam sclerotherapy. All patients were monitored by evaluating the duplex, the CEAP clinical classification, the VCSS and the CIVIQ-20 at 1 month and 3 month follow-up. Result: Significant clinical improvement with the change of CEAP clinical classification: C2 decreased from 28.2% to 20.0%, C3 from 42.7% to 0%, C4 from 26.4% to 0.9%. Meanwhile C0 and C1 respectively increased to 2.7%  and 73.7%. VCSS decreased 2.1 points representing 50% and CIVIQ-20 decreased 24.9 points representing 58.8% at baseline (vs 18.8 ± 2.0) after 3 months of treatment significantly (p<0.001). The complete occlusion rate was 66.4%, partial occlusion 20.0% and the fail rate 13.6%. Complications of the treatment include pain along the vein treated 44.5% and hyperpigmentation 70.0%. Conclusion: Foam sclerotherapy is an effective, safe, and minimally invasive endovenous  treatment for chronic venous incompetence with a low rate of complications.

Article Details

References

1. Beckitt T, Elstone A, Ashley S (2011) Air versus physiological gas for ultrasound guided foam sclerotherapy treatment of varicose veins. Eur J Vasc Endovasc Surg 42: 115-119.
2. Blaise S, Bosson JL, and Diamand JM (2010) Ultrasound-guided sclerotherapy of the great saphenous vein with 1% vs. 3% polidocanol foam: A multicentre double-blind randomised trial with 3-year follow-up. Eur J Vasc Endovasc Surg 39: 779-786.
3. Coleridge-Smith P, Lok C, and Ramelet A-A (2005) Venous leg ulcer: A meta-analysis of adjunctive therapy with micronized purified flavonoid fraction. European journal of vascular and endovascular surgery 30: 198-208.
4. Coleridge-Smith P, Labropoulos N, Partsch H et al (2006) Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs-UIP consensus document. Part I. Basic principles. European journal of vascular and endovascular surgery 31: 83-92.
5. Figueiredo M, Araujo S, Barros N Jr et al (2009) Results of surgical treatment compared with ultrasound-guided foam sclerotherapy in patients with varicose veins: A prospective randomised study. Eur J Vasc Endovasc Surg 38: 758-763.
6. Kundu S, Lurie F, Millward SF et al (2007) Recommended reporting standards for endovenous ablation for the treatment of venous insufficiency: Joint statement of The American Venous Forum and The Society of Interventional Radiology. J Vasc Surg 46: 582-589.
7. O'Hare J, Parkin D, Vandenbroeck C et al (2008) Mid term results of ultrasound guided foam sclerotherapy for complicated and uncomplicated varicose veins. European Journal of Vascular and Endovascular Surgery 36: 109-113.
8. Rabe E, Otto J, Schliephake D et al (2008) Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): A randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 35: 238-245.
9. Rabe E, Breu FX, Cavezzi A et al (2014) European guidelines for sclerotherapy in chronic venous disorders. Phlebology 29: 338-354.
10. Yamaki T, Nozaki M, Sakurai H et al (2009) Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg 37: 343-348.